0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza Daignostic Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-12A5908
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Influenza Daignostic Market Insights Forecast to 2028
BUY CHAPTERS

Global Influenza Daignostic Market Research Report 2025

Code: QYRE-Auto-12A5908
Report
July 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Influenza Daignostic Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Influenza Daignostic Market

Influenza Daignostic Market

The global market for Influenza Daignostic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Increasing prevalence of influenza, growing awareness for early detection using specific diagnostic tests,
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Influenza Daignostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Daignostic.
The Influenza Daignostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Influenza Daignostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Daignostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Influenza Daignostic Market Report

Report Metric Details
Report Name Influenza Daignostic Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, BIOMÉRIEUX, Roche, Becton Dickinson And Company, Meridian Bioscience, Quidel Corporation, Hologic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Influenza Daignostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Influenza Daignostic Market report?

Ans: The main players in the Influenza Daignostic Market are Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, BIOMÉRIEUX, Roche, Becton Dickinson And Company, Meridian Bioscience, Quidel Corporation, Hologic

What are the Application segmentation covered in the Influenza Daignostic Market report?

Ans: The Applications covered in the Influenza Daignostic Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Influenza Daignostic Market report?

Ans: The Types covered in the Influenza Daignostic Market report are Rapid Flu Detection Test, Virus Detection, Direct Fluorescent Antibody (DFA) Test, Serological Testing

Recommended Reports

Influenza & Flu Diagnosis

Diagnostic Equipment & Kits

Diagnostics Technology

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Daignostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Rapid Flu Detection Test
1.2.3 Virus Detection
1.2.4 Direct Fluorescent Antibody (DFA) Test
1.2.5 Serological Testing
1.3 Market by Application
1.3.1 Global Influenza Daignostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Influenza Daignostic Market Perspective (2020-2031)
2.2 Global Influenza Daignostic Growth Trends by Region
2.2.1 Global Influenza Daignostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Influenza Daignostic Historic Market Size by Region (2020-2025)
2.2.3 Influenza Daignostic Forecasted Market Size by Region (2026-2031)
2.3 Influenza Daignostic Market Dynamics
2.3.1 Influenza Daignostic Industry Trends
2.3.2 Influenza Daignostic Market Drivers
2.3.3 Influenza Daignostic Market Challenges
2.3.4 Influenza Daignostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Daignostic Players by Revenue
3.1.1 Global Top Influenza Daignostic Players by Revenue (2020-2025)
3.1.2 Global Influenza Daignostic Revenue Market Share by Players (2020-2025)
3.2 Global Influenza Daignostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Influenza Daignostic Revenue
3.4 Global Influenza Daignostic Market Concentration Ratio
3.4.1 Global Influenza Daignostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Daignostic Revenue in 2024
3.5 Global Key Players of Influenza Daignostic Head office and Area Served
3.6 Global Key Players of Influenza Daignostic, Product and Application
3.7 Global Key Players of Influenza Daignostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Daignostic Breakdown Data by Type
4.1 Global Influenza Daignostic Historic Market Size by Type (2020-2025)
4.2 Global Influenza Daignostic Forecasted Market Size by Type (2026-2031)
5 Influenza Daignostic Breakdown Data by Application
5.1 Global Influenza Daignostic Historic Market Size by Application (2020-2025)
5.2 Global Influenza Daignostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Influenza Daignostic Market Size (2020-2031)
6.2 North America Influenza Daignostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Influenza Daignostic Market Size by Country (2020-2025)
6.4 North America Influenza Daignostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Influenza Daignostic Market Size (2020-2031)
7.2 Europe Influenza Daignostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Influenza Daignostic Market Size by Country (2020-2025)
7.4 Europe Influenza Daignostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Influenza Daignostic Market Size (2020-2031)
8.2 Asia-Pacific Influenza Daignostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Influenza Daignostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Influenza Daignostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Influenza Daignostic Market Size (2020-2031)
9.2 Latin America Influenza Daignostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Influenza Daignostic Market Size by Country (2020-2025)
9.4 Latin America Influenza Daignostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Daignostic Market Size (2020-2031)
10.2 Middle East & Africa Influenza Daignostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Influenza Daignostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Influenza Daignostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Influenza Daignostic Introduction
11.1.4 Thermo Fisher Scientific Revenue in Influenza Daignostic Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Influenza Daignostic Introduction
11.2.4 Abbott Laboratories Revenue in Influenza Daignostic Business (2020-2025)
11.2.5 Abbott Laboratories Recent Development
11.3 Danaher Corporation
11.3.1 Danaher Corporation Company Details
11.3.2 Danaher Corporation Business Overview
11.3.3 Danaher Corporation Influenza Daignostic Introduction
11.3.4 Danaher Corporation Revenue in Influenza Daignostic Business (2020-2025)
11.3.5 Danaher Corporation Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Influenza Daignostic Introduction
11.4.4 Bio-Rad Laboratories Revenue in Influenza Daignostic Business (2020-2025)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 BIOMÉRIEUX
11.5.1 BIOMÉRIEUX Company Details
11.5.2 BIOMÉRIEUX Business Overview
11.5.3 BIOMÉRIEUX Influenza Daignostic Introduction
11.5.4 BIOMÉRIEUX Revenue in Influenza Daignostic Business (2020-2025)
11.5.5 BIOMÉRIEUX Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Influenza Daignostic Introduction
11.6.4 Roche Revenue in Influenza Daignostic Business (2020-2025)
11.6.5 Roche Recent Development
11.7 Becton Dickinson And Company
11.7.1 Becton Dickinson And Company Company Details
11.7.2 Becton Dickinson And Company Business Overview
11.7.3 Becton Dickinson And Company Influenza Daignostic Introduction
11.7.4 Becton Dickinson And Company Revenue in Influenza Daignostic Business (2020-2025)
11.7.5 Becton Dickinson And Company Recent Development
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Details
11.8.2 Meridian Bioscience Business Overview
11.8.3 Meridian Bioscience Influenza Daignostic Introduction
11.8.4 Meridian Bioscience Revenue in Influenza Daignostic Business (2020-2025)
11.8.5 Meridian Bioscience Recent Development
11.9 Quidel Corporation
11.9.1 Quidel Corporation Company Details
11.9.2 Quidel Corporation Business Overview
11.9.3 Quidel Corporation Influenza Daignostic Introduction
11.9.4 Quidel Corporation Revenue in Influenza Daignostic Business (2020-2025)
11.9.5 Quidel Corporation Recent Development
11.10 Hologic
11.10.1 Hologic Company Details
11.10.2 Hologic Business Overview
11.10.3 Hologic Influenza Daignostic Introduction
11.10.4 Hologic Revenue in Influenza Daignostic Business (2020-2025)
11.10.5 Hologic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Influenza Daignostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Rapid Flu Detection Test
 Table 3. Key Players of Virus Detection
 Table 4. Key Players of Direct Fluorescent Antibody (DFA) Test
 Table 5. Key Players of Serological Testing
 Table 6. Global Influenza Daignostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Influenza Daignostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Influenza Daignostic Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Influenza Daignostic Market Share by Region (2020-2025)
 Table 10. Global Influenza Daignostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Influenza Daignostic Market Share by Region (2026-2031)
 Table 12. Influenza Daignostic Market Trends
 Table 13. Influenza Daignostic Market Drivers
 Table 14. Influenza Daignostic Market Challenges
 Table 15. Influenza Daignostic Market Restraints
 Table 16. Global Influenza Daignostic Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Influenza Daignostic Market Share by Players (2020-2025)
 Table 18. Global Top Influenza Daignostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Daignostic as of 2024)
 Table 19. Ranking of Global Top Influenza Daignostic Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Influenza Daignostic Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Influenza Daignostic, Headquarters and Area Served
 Table 22. Global Key Players of Influenza Daignostic, Product and Application
 Table 23. Global Key Players of Influenza Daignostic, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Influenza Daignostic Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Influenza Daignostic Revenue Market Share by Type (2020-2025)
 Table 27. Global Influenza Daignostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Influenza Daignostic Revenue Market Share by Type (2026-2031)
 Table 29. Global Influenza Daignostic Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Influenza Daignostic Revenue Market Share by Application (2020-2025)
 Table 31. Global Influenza Daignostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Influenza Daignostic Revenue Market Share by Application (2026-2031)
 Table 33. North America Influenza Daignostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Influenza Daignostic Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Influenza Daignostic Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Influenza Daignostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Influenza Daignostic Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Influenza Daignostic Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Influenza Daignostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Influenza Daignostic Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Influenza Daignostic Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Influenza Daignostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Influenza Daignostic Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Influenza Daignostic Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Influenza Daignostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Influenza Daignostic Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Influenza Daignostic Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Thermo Fisher Scientific Company Details
 Table 49. Thermo Fisher Scientific Business Overview
 Table 50. Thermo Fisher Scientific Influenza Daignostic Product
 Table 51. Thermo Fisher Scientific Revenue in Influenza Daignostic Business (2020-2025) & (US$ Million)
 Table 52. Thermo Fisher Scientific Recent Development
 Table 53. Abbott Laboratories Company Details
 Table 54. Abbott Laboratories Business Overview
 Table 55. Abbott Laboratories Influenza Daignostic Product
 Table 56. Abbott Laboratories Revenue in Influenza Daignostic Business (2020-2025) & (US$ Million)
 Table 57. Abbott Laboratories Recent Development
 Table 58. Danaher Corporation Company Details
 Table 59. Danaher Corporation Business Overview
 Table 60. Danaher Corporation Influenza Daignostic Product
 Table 61. Danaher Corporation Revenue in Influenza Daignostic Business (2020-2025) & (US$ Million)
 Table 62. Danaher Corporation Recent Development
 Table 63. Bio-Rad Laboratories Company Details
 Table 64. Bio-Rad Laboratories Business Overview
 Table 65. Bio-Rad Laboratories Influenza Daignostic Product
 Table 66. Bio-Rad Laboratories Revenue in Influenza Daignostic Business (2020-2025) & (US$ Million)
 Table 67. Bio-Rad Laboratories Recent Development
 Table 68. BIOMÉRIEUX Company Details
 Table 69. BIOMÉRIEUX Business Overview
 Table 70. BIOMÉRIEUX Influenza Daignostic Product
 Table 71. BIOMÉRIEUX Revenue in Influenza Daignostic Business (2020-2025) & (US$ Million)
 Table 72. BIOMÉRIEUX Recent Development
 Table 73. Roche Company Details
 Table 74. Roche Business Overview
 Table 75. Roche Influenza Daignostic Product
 Table 76. Roche Revenue in Influenza Daignostic Business (2020-2025) & (US$ Million)
 Table 77. Roche Recent Development
 Table 78. Becton Dickinson And Company Company Details
 Table 79. Becton Dickinson And Company Business Overview
 Table 80. Becton Dickinson And Company Influenza Daignostic Product
 Table 81. Becton Dickinson And Company Revenue in Influenza Daignostic Business (2020-2025) & (US$ Million)
 Table 82. Becton Dickinson And Company Recent Development
 Table 83. Meridian Bioscience Company Details
 Table 84. Meridian Bioscience Business Overview
 Table 85. Meridian Bioscience Influenza Daignostic Product
 Table 86. Meridian Bioscience Revenue in Influenza Daignostic Business (2020-2025) & (US$ Million)
 Table 87. Meridian Bioscience Recent Development
 Table 88. Quidel Corporation Company Details
 Table 89. Quidel Corporation Business Overview
 Table 90. Quidel Corporation Influenza Daignostic Product
 Table 91. Quidel Corporation Revenue in Influenza Daignostic Business (2020-2025) & (US$ Million)
 Table 92. Quidel Corporation Recent Development
 Table 93. Hologic Company Details
 Table 94. Hologic Business Overview
 Table 95. Hologic Influenza Daignostic Product
 Table 96. Hologic Revenue in Influenza Daignostic Business (2020-2025) & (US$ Million)
 Table 97. Hologic Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Influenza Daignostic Picture
 Figure 2. Global Influenza Daignostic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Influenza Daignostic Market Share by Type: 2024 VS 2031
 Figure 4. Rapid Flu Detection Test Features
 Figure 5. Virus Detection Features
 Figure 6. Direct Fluorescent Antibody (DFA) Test Features
 Figure 7. Serological Testing Features
 Figure 8. Global Influenza Daignostic Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Influenza Daignostic Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. Others Case Studies
 Figure 13. Influenza Daignostic Report Years Considered
 Figure 14. Global Influenza Daignostic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Influenza Daignostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Influenza Daignostic Market Share by Region: 2024 VS 2031
 Figure 17. Global Influenza Daignostic Market Share by Players in 2024
 Figure 18. Global Top Influenza Daignostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Daignostic as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Influenza Daignostic Revenue in 2024
 Figure 20. North America Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Influenza Daignostic Market Share by Country (2020-2031)
 Figure 22. United States Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Influenza Daignostic Market Share by Country (2020-2031)
 Figure 26. Germany Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Influenza Daignostic Market Share by Region (2020-2031)
 Figure 34. China Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Influenza Daignostic Market Share by Country (2020-2031)
 Figure 42. Mexico Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Influenza Daignostic Market Share by Country (2020-2031)
 Figure 46. Turkey Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Influenza Daignostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Influenza Daignostic Business (2020-2025)
 Figure 50. Abbott Laboratories Revenue Growth Rate in Influenza Daignostic Business (2020-2025)
 Figure 51. Danaher Corporation Revenue Growth Rate in Influenza Daignostic Business (2020-2025)
 Figure 52. Bio-Rad Laboratories Revenue Growth Rate in Influenza Daignostic Business (2020-2025)
 Figure 53. BIOMÉRIEUX Revenue Growth Rate in Influenza Daignostic Business (2020-2025)
 Figure 54. Roche Revenue Growth Rate in Influenza Daignostic Business (2020-2025)
 Figure 55. Becton Dickinson And Company Revenue Growth Rate in Influenza Daignostic Business (2020-2025)
 Figure 56. Meridian Bioscience Revenue Growth Rate in Influenza Daignostic Business (2020-2025)
 Figure 57. Quidel Corporation Revenue Growth Rate in Influenza Daignostic Business (2020-2025)
 Figure 58. Hologic Revenue Growth Rate in Influenza Daignostic Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart